Corrigendum to <‘Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials’>[J Microbiol Immunol Infect 55 (1) (2022) 26–35, (S168411822030253X), (10.1016/j.jmii.2020.11.001)]

Shao Huan Lan, Chih Cheng Lai, Shen Peng Chang, Chun Chun Hsu, Cheng Hsin Chen, Ya Hui Wang, Yueh Lan Huang, Cheng Yi Wang, You Shuei Lin

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Corrigendum to <‘Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials’>[J Microbiol Immunol Infect 55 (1) (2022) 26–35, (S168411822030253X), (10.1016/j.jmii.2020.11.001)]'. Together they form a unique fingerprint.